Nizankowska M H, Oficjalska-Młyńczak J, Lukasik-Czerek A, Popiela G, Zajac-Pytrus H, Turno-Krecicka A
Z Katedry i Kliniki Okulistyki AM we Wrocławiu.
Klin Oczna. 1995 Sep-Oct;97(9-10):279-81.
To evaluate the results of PRK performed between 1990 and 1994 in Wroclaw University Eye Clinic.
PRK was performed in 630 eyes with: (1) PDR--451 immediately treated eyes (moderate PDR--184 eyes, with "high-risk" characteristics--227 eyes, PDR advanced--after cryopexion--40 eyes); (2) severe NPDR--119 eyes (with PDR in fellow eye or with ME) and (3) less severe DR--60 eyes treated with immediate or delayed, full or mild scatter coagulation (with macular edema, both eye moderate NPDR, other systemic risk factors). Follow-up treatment: Additional scatter or local photocoagulation was performed in 34 cases increasing activity of neovascularisation or increase in frequency/extend of vitreous hemorrhage.
In a period 3 to 36 months of follow-up (mean period = 25 months) in the group of 451 eyes with PDR 28.2% of eyes showed visual improvement, 48.3% of eyes showed no change and 23.5% of eyes worsened. In the group of 119 eyes with severe NPRD 75.6% showed visual improvement and 24.4% showed no change. In the group of 60 eyes with less severe DR 27.8% showed improvement, 36.7% showed no change and 35.5% worsened.
Our results are relatively good and in agreement with other studies.
评估1990年至1994年在弗罗茨瓦夫大学眼科诊所进行的准分子激光角膜切削术(PRK)的结果。
对630只眼进行PRK,其中包括:(1)增殖性糖尿病性视网膜病变(PDR)——451只立即接受治疗的眼(中度PDR——184只眼,具有“高危”特征——227只眼,晚期PDR——冷冻治疗后——40只眼);(2)重度非增殖性糖尿病性视网膜病变(NPDR)——119只眼(对侧眼有PDR或有黄斑水肿);(3)轻度糖尿病性视网膜病变(DR)——60只眼,接受立即或延迟的全视网膜或轻度散射光凝治疗(伴有黄斑水肿、双眼中度NPDR、其他全身危险因素)。随访治疗:34例因新生血管活动增加或玻璃体出血频率/范围扩大而进行了额外的散射或局部光凝治疗。
在451只患有PDR的眼中,随访3至36个月(平均25个月),28.2%的眼视力改善,48.3%的眼视力无变化,23.5%的眼视力恶化。在119只患有重度NPDR的眼中,75.6%的眼视力改善,24.4%的眼视力无变化。在60只患有轻度DR的眼中,27.8%的眼视力改善,36.7%的眼视力无变化,35.5%的眼视力恶化。
我们的结果相对较好,与其他研究结果一致。